Connect with us

Global News

Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business

Published

on

BOSTON and LAUSANNE, Switzerland, Jan. 10, 2022 /PRNewswire/ — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced key additions to their leadership team with the hiring of Peter Casasanto as Chief BioPharma Officer and Abhimanyu (Abhi) Verma as Chief Technology Officer. The additions are part of SOPHiA GENETICS’ strategy to enhance its business in the pharmaceutical industry. Peter and Abhi will help the company drive deeper with a focus on leveraging data for the BioPharma industry.

“We have undergone considerable growth in recent months with exciting expansions to our global footprint and BioPharma business,” said Jurgi Camblong, co-founder and CEO of SOPHiA GENETICS. “Placing a priority on BioPharma and technology innovation will drive our overall vision to support and accelerate the evolving data research needs of healthcare institutions around the world. Peter and Abhi bring diverse insights and leadership experience, and their expertise will be vital to ensuring we deliver on this vision.”

Peter brings more than 15 years of life sciences industry experience in business development and sales strategy to SOPHiA GENETICS’ growing portfolio.  Prior to this role, he was Vice President of New Commercialization Initiatives at CellCarta where he led commercial strategies for corporate initiatives, including companion diagnostics/single-site IVD launch and Go-to-Market strategy for an in-house developed SaaS analytics platform, as well as AI-driven initiatives for multiomic-based insights and predictions. Peter also held corporate and business development roles at Tempus Labs, NeoGenomics and LabCorp. He started his career as a scientist at Merck’s Vaccines & Biologics Lab, eventually moving on to lead business development efforts for PPD’s newly acquired vaccines division.

Abhi brings more than 17 years of Life Sciences industry experience in leading global multifunctional organizations to develop technology and data driven capabilities and platforms to accelerate drug R&D and patient access to breakthrough therapies. Previously, Abhi served at Novartis where he had several leadership roles spanning multiple functions, locations and therapy areas in applied technology innovation, real world evidence, drug development, enterprise technologies, IT strategy, data science and AI. He incubated and scaled several technology and data centric platforms, products and capabilities that underpin the digital transformation at Novartis. The early part of his career was spent at GE and Patni Computers.

“I am excited and incredibly proud to join an organization that is taking such a thoughtful approach to harnessing and standardizing complex genotypic, radiomic and phenotypic datasets to advance both patient care and drug development,” said Peter. “Having previously been a part of an organization with a centralized focus, I’ve seen first-hand the importance of a more decentralized approach to capture data globally. Big data and machine learning will significantly impact the healthcare ecosystem, but without an intelligent analytics platform to harmonize and make sense of the data, the utility will be limited. Having a platform like SOPHiA DDM that leverages a global network will be increasingly important to accelerate recruitment and site selection and enhance trial design and targeted patient selection.”

“As someone who is motivated by creating impact on patients, I am tremendously excited and humbled to have the opportunity to be part of a team and culture that is intellectually honest, passionate, grounded, and is taking a precision approach towards multimodal insights to support healthcare institutions and accelerate R&D,” said Abhi. “The Sophia DDM platform is unique in its capabilities, as it can bring together diverse datasets to generate multi modal disease and patient insights powered by AI while enabling the sharing of knowledge and insights across the clinical research and healthcare community.  I am joining a team that is responding to very complex challenges, and I look forward to being part of the journey to further drive and accelerate the technology innovation and product development.”   

Peter holds an MBA in Pharmaceutical Management from Drexel’s LeBow College of Business, a Master of Science degree in Biomedical Chemistry from Thomas Jefferson Medical School, and a Bachelor of Science degree in Immunology & Genomics from the University of Maryland at College Park.

Abhi holds an MBA from the Indian School of Business, a Master of Science degree in Pharmaceutical Medicine, and is an Engineer. He is also co-founder of the non-profit Health Hacking Lab.

About SOPHiA GENETICSSOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 790 hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn and Instagram. Where others see data, we see answers. 

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures, unless specified otherwise. The information included in this press release is about products that may or may not be available in different countries and, if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact [email protected] to obtain the appropriate product information for your country of residence.

SOPHiA GENETICS Forward-Looking Statements:This press release contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy, products and technology, as well as plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including those described in our filings with the U.S. Securities and Exchange Commission. No assurance can be given that such future results will be achieved. Such forward-looking statements contained in this document speak only as of the date of this press release. We expressly disclaim any obligation or undertaking to update these forward-looking statements contained in this press release to reflect any change in our expectations or any change in events, conditions, or circumstances on which such statements are based, unless required to do so by applicable law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.

Logo – https://mma.prnewswire.com/media/1673202/SOPHiA_GENETICS_Logo.jpg

Disclaimer:
This Press Release has not been vetted or endorsed by The Eastern Herald’s editorial staff.

Read More

Original Post: easternherald.com

Global News

ViewSonic Announced Winners of the Global “Acceleration for All” Awards

Published

on

BREA, Calif., Jan. 14, 2022 /PRNewswire/ — ViewSonic[i], a leading global provider of visual solutions, and Hustle Fund, a pre-seed venture capital firm that invests in early-stage startups, announced the Top 5 winners of the Acceleration for All Awards (The Affies) during an exclusive online awards ceremony held on January 12, 2022. The ceremony was hosted by comedian, actor and writer, Irene Tu, and included interviews with industry leaders.

“With over 1500 pitches from 30 industries representing an array of early-stage and mature startups, we are delighted to announce the Top 5 winners of the ‘Affies’. Allowing us to offer real solutions, such as tools, resources, and opportunities for these great founders,” said Oscar Lin, General Manager of the Monitor Business Unit at ViewSonic. “By utilizing ViewSonic’s innovative devices and software, we hope to help passionate entrepreneurs and startups learn, grow, and realize their dreams.”

The five categories included: Best B2B, Best Consumer, Best Creator, Best Frontier, and the public-voted People’s Choice. The winners of each of the categories were announced and given the opportunity of an investment or exclusive weekly one-on-one meetings with the Hustle Fund General Partners. They also received ViewSonic products valued at USD 6,000.

ViewSonic also provided the audience who joined the online ceremony with prizes, including a VG2440V video conferencing monitor, a TD1655 portable touch monitor, and a VG3456 ultra-wide docking monitor. For more information on The Affies, please visit the campaign website.

Winners of The Affies
Best B2B: Roberto Inetti of ROBOAMP. A SaaS company looking to decrease website loading time to a second or less with a single line of code. Best Creator: Helen Huang of Co.Lab. An e-learning platform for live instructor-less classes. Best Consumer: Tavis Schriefer of teleCalm. A stress-free phone service that protects seniors and empowers caregivers through filtered incoming and outgoing calls. Best Frontier: Robert Luo of Mi Terro. A US-based company with a solution to re-engineer agricultural waste into plastic-alternative packaging material. People’s Choice: Danielle Lumetta of Before Noon. A self-care membership platform focused on releasing stress.About ViewSonic

Founded in California, ViewSonic is a leading global provider of visual solutions and conducts business in over 100 countries worldwide. As an innovator and visionary, ViewSonic is committed to providing comprehensive hardware and software solutions that include monitors, projectors, digital signage, ViewBoard interactive displays, and myViewBoard software ecosystem. With over 30 years of expertise in visual displays, ViewSonic has established a strong position for delivering innovative and reliable solutions for education, enterprise, consumer, and professional markets and helping customers “See the Difference.” To find out more about ViewSonic, please visit www.viewsonic.com.

About Hustle Fund

Hustle Fund is a pre-seed/seed-stage fund based in San Francisco and Singapore founded in 2017 by Elizabeth Yin, Shiyan Koh, and Eric Bahn. From their combined experience as successful founders, tech employees, and investors, Hustle Fund’s General Partners learned that, despite entrenched stereotypes in the venture world, great founders look like anyone and come from anywhere. Hustle Fund’s core investment strategy is to invest in teams who demonstrate relentless speed and execution (defined as ‘hustle’) and has turned the VC model on its head. The investment team reviews over 600 deals per month, moves quickly to invest a modest initial check, and then works with the founder to monitor their speed/execution before qualifying startups for a larger, concentrated checks. Hustle Fund has developed an incredible global reputation with founders and investors alike.

[i] The Awards is hosted and sponsored by ViewSonic International Corp., located in New Taipei City, Taiwan. ViewSonic International Corp. is a subsidiary of ViewSonic Corp. located in California, USA.

Photo – https://mma.prnewswire.com/media/1726763/Image_1_Acceleration_for_All_Awards__The_Affies.jpg Logo – https://mma.prnewswire.com/media/1587181/Logo.jpg

Disclaimer:
This Press Release has not been vetted or endorsed by The Eastern Herald’s editorial staff.

Read More

Original Post: easternherald.com

Continue Reading

Global News

DevOps Institute Announces New Certifications, Expanded Lineup of Educational Experiences in 2022

Published

on

Company to release DevSecOps Practitioner and DevOps Engineering Foundation Certifications along with a webinar and event program to upskill humans in the digital age

LEHIGH ACRES, Fla., Jan. 12, 2022 /PRNewswire/ — DevOps Institute (https://devopsinstitute.com/), a professional member association and certification authority for advancing the human elements of DevOps, today announced its lineup for 2022 events and webinars and plans for two new DevOps certifications. The goal in 2022 is to advance the Humans of DevOps through skills, knowledge, ideas, and learning – or the SKIL Framework.

“In 2022, DevOps Institute continues to lead the charge toward human transformation with an exciting lineup of new and expanded opportunities for DevOps professionals,” said Jayne Groll, CEO of DevOps Institute. “As we ramp up our education and certification programs, we aim to empower the global member community with the skills and knowledge they need to further their careers and advance the DevOps initiatives at their organizations.”

What’s new in 2022:
New Certifications:DevSecOps Practitioner is the next level in the DevSecOps certification series. Building on DevSecOps Foundation, the Practitioner certification covers advanced DevSecOps practices and methods, architecture and infrastructure, technical implementation, practical maturity guides, and metrics to deliver better DevSecOps outcomes.DevOps Engineering Foundation explains many aspects of DevOps engineering that leaders and practitioners can execute upon. An engineering approach is critical to DevOps journeys. This certification covers the foundations of knowledge, principles and practices needed to engineer a successful DevOps solution. Learn more about certifications: https://devopsinstitute.com/certifications/SKILup Educational Experiences: IT professionals have always dealt with change, but never at the speed of the current digital transformation. The humans of DevOps are being asked to learn and implement new technologies at a pace that often outruns their current skill level. Upskilling has never been more important. SKILup Educational Experiences are DevOps-focused events designed to provide ‘just-in-time’ insights and education needed by DevOps professionals in a wide variety of disciplines. DevOps Institute aims to disrupt the typical technical conference format and focus on providing relevant content and learning in a safe and fun environment. Attendees can immediately put these insights into practice to meet the demands of business agility. SKILup Educational Experience opportunities include: SKILup Days: One-day virtual micro conferences with a singular, how-to focus. Featuring experts from the industry as well as enterprise DevOps leaders, SKILup Days include all elements of an in-person conference, including virtual sponsor booths, competitions and networking opportunities with other attendees and Speakers. SKILup Hours: Educational Webinars for IT Professionals. Each SKILup Hour includes a panel session that is moderated by industry experts; providing discreet buildable how-to knowledge on topics crossing people, process and technology.SKILup Festival 2022: A Live DevOps Educational Experience: DevOps Institute is excited to announce that our in-person experiences include high-level content as well as deep-dive technical sessions and workshops with some festival fun and entertainment mixed in. (Dates and locations to be determined.) Learn more about upcoming events: http://devopsinstitute.com/eventsAbout DevOps InstituteDevOps Institute is a professional member association and certification authority. DevOps Institute’s mission is to advance the human elements of DevOps. It is the unifying force of an open and growing professional community of IT practitioners, consultants, talent acquisition and executives helping pave the way to support digital transformation and the New IT.

Web | https://devopsinstitute.com/ Twitter | @DEVOPSINSTLinkedIn | /devops-instituteYouTube | DevOps InstituteInstagram | @humansofdevops

Media Contact:Jeremy DouglasCatapult PR-IR+1 [email protected]

Logo – https://mma.prnewswire.com/media/772398/DevOps_Institute_Logo.jpg

Disclaimer:
This Press Release has not been vetted or endorsed by The Eastern Herald’s editorial staff.

Read More

Article: easternherald.com

Continue Reading

Global News

Ascend to Build HMD Plant in China’s Jiangsu Province

Published

on

HOUSTON, Jan. 12, 2022 /PRNewswire/ — Ascend Performance Materials announced today it signed an investment agreement to construct a new hexamethylene diamine and specialty chemicals plant in Lianyungang, China in the Xuwei New Area Park. The new plant will be Ascend’s first chemical production facility and the largest investment the company has made outside of the United States.

The plant will produce HMD and specialty chemicals to supply Ascend’s global polyamide production and serve its regional customers.

“Our growth is driven by increasing market demand and growing collaboration with our customers globally,” said Phil McDivitt, Ascend’s president and CEO. “The materials we produce are helping drive technological transformations across markets, from e-mobility to automation. Our new HMD plant positions us to continue supporting these transformations well into the future.”

Ascend, a fully integrated producer of durable engineered materials, serves a variety of sectors including automotive, paints and coatings, electrical and electronics, consumer goods, and cable ties and fasteners.

“China and Asia remain high-growth markets for us,” said Dr. Kevin Wu, Ascend’s senior vice president and managing director for Asia. “This new plant is a symbol of our growth in the region and the partnerships we have developed. We thank the Xuwei New Area Park administrators and the officials in Lianyungang for their partnership in this project.”

Ascend signed a memorandum of understanding in November 2020 during CIIE in Shanghai with Xuwei New Area Park, witnessed by the leaders of Jiangsu Province and Lianyungang.

Ascend will begin construction later this year with a plant startup targeted for the second half of 2023.

The announcement of the new site construction follows a series of acquisitions and capacity expansions to enable regional growth and continued global supply security. In 2018, Ascend made its first acquisition in Tilburg, Netherlands, followed by acquisitions in Mozzate, Italy; Suzhou, China; and Fosses, France. Ascend will also complete an acquisition in San Jose Iturbide, Mexico and the construction of Ascend Asia Innovation Center later this year.

About Ascend Performance Materials

Ascend Performance Materials makes high-performance materials for everyday essentials and new technologies. Our focus is on improving quality of life and inspiring a better tomorrow through innovation. Based in Houston, Texas, and with regional offices in Shanghai, Brussels and Detroit, we are a fully integrated material solutions provider with nine global manufacturing facilities in North America, Europe and Asia. Our 2,600-person global workforce makes the engineered materials, fabrics, fibers and chemicals used to make safer vehicles, cleaner energy, better medical devices, smarter appliances and longer-lasting apparel and consumer goods. We are committed to safety, sustainability, inclusion and diversity, and to the success of our customers and our communities.

Learn more about Ascend at www.ascendmaterials.com.

Contact: Alison Jahn, +1-713-210-9809,[email protected] 

Photo – https://mma.prnewswire.com/media/1724978/IMG_1224.jpg  Logo – https://mma.prnewswire.com/media/1326397/ASCEND_Logo.jpg  

Disclaimer:
This Press Release has not been vetted or endorsed by The Eastern Herald’s editorial staff.

Read More

Article: easternherald.com

Continue Reading

Trending

ConnectingWire.com